What You Should Know:
– Xealth, the leader in digital health enablement for health systems, today announced a strategic investment from Morningside Ventures, a leading investor in healthcare innovation.
– This investment will strengthen Morningside’s digital health portfolio and expand Xealth’s footprint within health systems, helping them to manage and deploy their digital health formularies more effectively.
Morningside Ventures Expands Digital Health Portfolio with Xealth Investment
Morningside Ventures, a long-term investor in novel science and technology, focuses on ethical company-building across life sciences, digital health, AI, materials, and technology. Founded in 1986 as the Chan family’s family office, its philanthropic contributions include the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.
Expanding its portfolio of over 40 digital health companies, Morningside has invested in Xealth, a platform that integrates digital health tools into clinical workflows. Xealth streamlines provider-patient interactions, embedding digital vendors, programs, and therapeutics into care delivery while enhancing clinical and financial outcomes.
“The healthcare system demands seamless digital solutions that connect providers with patients,” said Stephen Bruso of Morningside Ventures. “Xealth’s ability to automate digital interventions within the EHR aligns with our vision for a more connected, efficient healthcare ecosystem.”
Xealth powers digital health programs for major U.S. health systems, offering custom analytics to track, analyze, and optimize digital health initiatives. The platform has facilitated 12 million orders, engaged 100,000 providers, and reached three million patients, reinforcing its impact on digital healthcare.
